Jefferies lowered the firm’s price target on Cigna (CI) to $330 from $333 and keeps a Buy rating on the shares. The firm adjusted estimates among its managed care coverage following a deep dive into health insurance plans offered on the Health Insurance Exchange.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CI:
- AxoGen jumps after Cigna picks up Avance nerve graft
- 3 “Strong Buy” Blue Chip Stocks to Buy in April 2026, According to Analysts
- One in seven enrollees in ACA plans failed to make payments this year, WSJ says
- Midday Fly By: Health insurers get ‘positive surprise’ from CMS
- CMS finalizes 2027 Medicare Advantage payments with 2.48% increase
